For Investors


The Cutting Edge of Cancer Innovation

Oncolytics Biotech Inc. is a developer of oncolytic viruses as cancer therapeutics and is listed on the Toronto Stock Exchange (TSX:ONC) and the NASDAQ (NASDAQ:ONCY). In addition to the information available on this site, investors can access the Company’s regulatory filings on the SEDAR website at www.sedar.com and on the EDGAR website at www.sec.gov.

Financials

Access our quarterly and year-end financial statements, MD&A, information circulars and annual reports.

View Financials

Stock Information

View our stock charts and other information about our stock (TSX:ONC, NASDAQ:ONCY).

View Stock Information

Analyst Coverage

Find out which analysts and institutions provide coverage of Oncolytics.

View Analyst Coverage

Investor Presentation

Click here to load our most recent investor presentation.

View Presentation

Latest News

April 20, 2015 Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Data at the 2015 AACR Annual Meeting
April 17, 2015 Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Malignant Gliomas
April 15, 2015 Oncolytics Biotech® Inc. Presents at UK Immuno-oncology Meeting
Sign up to receive e-mail updates *